(2026). Discordant sestamibi uptake in synchronous parathyroid carcinoma and adenoma. Endocrinology, Diabetes & Metabolism Case Reports.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Discordant Sestamibi Uptake in Synchronous Parathyroid Carcinoma and Adenoma."
Endocrinology, Diabetes & Metabolism Case Reports 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Discordant Sestamibi Uptake in Synchronous Parathyroid Carcinoma and Adenoma."
Endocrinology, Diabetes & Metabolism Case Reports, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.